Schering-Plough
SGP
#508
Rank
S$59.42 B
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Schering-Plough was a major American pharmaceutical company that developed and marketed a range of prescription drugs. In 2009, Schering-Plough was acquired by Merck & Co. in a $41 billion USD deal.

Earnings for Schering-Plough (SGP.defunct.2009)

Earnings in 2008: S$2.63 Billion

According to Schering-Plough's latest financial reports the company's current earnings are N/A. In 2008 the company made an earning of S$2.63 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Schering-Plough from 1996 to 2008

Annual earnings

Year Earnings Change
2008S$2.63 B
2006S$1.90 B198.39%
2005S$0.63 B-395.83%
2004-S$0.22 Billion265.22%
2003-S$59.19 Million-102.01%
2002S$2.94 B3.62%
2001S$2.84 B-5.39%
2000S$3.00 B
1998S$2.48 B22.34%
1997S$2.02 B38.9%
1996S$1.45 B